Presentations -
-
Cancer-testis antigen BORIS is a novel prognostic marker for patients with esophageal cancer.
Koji Okabayashi, Tomonobu Fujita, Junichirou Miyazaki, Tsutomu Okada, Takashi Iwata, Nobumaru Hirao, Shinobu Noji, Nobuo Tsukamoto, Hiroki Ochiai, Hirotoshi Hasegawa, Hiroya Takeuchi, Yuko Kitagawa, Yutaka Kawakami.
第69回日本癌学会 (大阪国際会議場) ,
2010.09,Poster presentation
-
Eradication of cancer metastasis by breaking a crucial link to systemic immunosuppression underlying poor outcome.
Chie Kudo-Saito
第69回日本癌学会 (大阪国際会議場) ,
2010.09,Oral presentation (general)
-
MicroRNA-222 is a potential target for developing blood-based diagnostic methods and treatment of malignant glioma.
Ryo Ueda, Qian Li, Tomonori Yaguchi, Nobuyoshi Kosaka, Tomonobu Fujita, Hideho Okada, Takahiro Ochiya, Yutaka Kawakami.
第69回日本癌学会 (大阪国際会議場) ,
2010.09,Poster presentation
-
A novel immunotherapy with HVJ envelope to malignant melanoma
Eiji Kiyohara, Atsushi Tanemura, Megumi Nishioka, Takashi Yamanaka, Mamoru Tani, Chun Man Lee, Katsuto Tamai, Ichiro Katayama, Yasufumi Kaneda, Yutaka Kawakami.
第69回日本癌学会 (大阪国際会議場) ,
2010.09,Oral presentation (general)
-
マウス神経幹細胞におけるMIFの機能解析
大多茂樹、河上裕、岡野栄之、戸田正博
Neuro 2010 (神戸コンベンションセンター) ,
2010.09,Poster presentation
-
Possible improvement of cancer immunotherapy based on tha analyses of anti-tumor immune responses in human.
Yutaka Kawakami, Chie kudo-Saito,Hidetoshi Sumimoto, Ryo Ueda, Nobuo Tsukamoto, Tomonobu Fujita, Toshiharu Sakurai, Tomonori Yaguchi
金沢国際がん生物学シンポジウム (KKRホテル金沢) ,
2010.08,Oral presentation (invited, special)
-
Reversal of cancer induced immunosuppression by targeting altered signaling molecules in cancer cells and immune cells.
Yutaka Kawakami, Hidetoshi sumimoto, Tomoko Iwata-Kajihara, Tomonori Yaguchi, Naoshi Kawamura, Chie Kudo-Saito, Nobuo Tsukamoto.
14thInternational Congress of Immunology 2010 (Kobe International Convention Center) ,
2010.08,Symposium, workshop panel (nominated)
-
Reversal of cancer induced immunosuppression by targeting altered signaling molecules in cancer cells and immune cells.
Yutaka Kawakami, Hidetoshi sumimoto, Tomoko Iwata-Kajihara, Tomonori Yaguchi, Naoshi Kawamura, Chie Kudo-Saito, Nobuo Tsukamoto.
14thInternational Congress of Immunology 2010 (Kobe International Convention Center) ,
2010.08,Poster presentation
-
Immune escape of human melanoma via activated Wnt/β-catenin signaling.
Tomonori Yaguchi, Yasufumi Goto, Kenji Kido, Hiroshi Mochimaru, Toshiharu Sakurai, Nobuo Tsukamoto, Chie Kudo-Saito, Tomonobu Fujita, Hidetoshi Sumimoto, Yutaka Kawakami.
14thInternational Congress of Immunology 2010 (Kobe International Convention Center) ,
2010.08,Poster presentation
-
Immunosuppression mediated by mesenchymal stem cells and Treg cells during Snail-induced cancer EMT.
Chie Kudo-Saito, Yutaka Kawakami.
14thInternational Congress of Immunology 2010 (Kobe International Convention Center) ,
2010.08,Poster presentation
-
Immunosuppression by human cancer cells and it's control for effective immunotherapy.
Yutaka kawakami, Chie Kudo-Saito, Hidetoshi Sumimoto, Nobuo Tsukamoto, Ryo Ueda, Tomonori Yaguchi.
14thInternational Congress of Immunology 2010 (Kobe International Convention Center) ,
2010.08,Oral presentation (invited, special)
-
悪性黒色腫および樹状細胞でのWnt/β-cateninシグナル亢進はがん微小環境での免疫抑制に関与する
谷口智憲、守井賢二、西尾浩、桜井敏晴、塚本信夫、工藤千恵、藤田知信、河上裕
第14回日本がん免疫学会 (KKRホテル熊本) ,
2010.07,Oral presentation (general)
-
シンポジウム２「次世代がん免疫療法の開発に向けた基礎・応用研究、「がん免疫逃避機構とその制御」
河上裕、住本秀敏、工藤千恵、塚本信夫、植田良、梶原知子、川村直,谷口智憲
第14回日本がん免疫学会 (KKRホテル熊本) ,
2010.07,Symposium, workshop panel (nominated)
-
卵巣癌におけるNF-κBシグナルの亢進は、IL-6の産生およびMDSCの誘導により、免疫抑制に関与する
西尾浩、谷口智憲、岩田卓、桜井敏晴、塚本信夫、工藤千恵、藤田知信、河上裕
第14回日本がん免疫学会 (KKRホテル熊本) ,
2010.07,Oral presentation (general)
-
MicroRNA-222 is a potential target for developing blood-based biomarker assay and treatment of malignant glioma.
Ryo Ueda, Li Qian, Tomonori Yaguchi, Nobuyoshi Kosaka, Tomonobu Fujita, Hideho Okada, Takahiro Ochiya, Yutaka Kawakami
第16回日本遺伝子治療学会 (栃木県総合文化センター) ,
2010.07,Poster presentation
-
がん関連微小環境における免疫抑制病態とがん細胞の免疫抵抗性の分子機構の解明とその制御
河上裕
第19回日本癌病態治療研究会 (東京ステーションコンファレンス) ,
2010.07,Oral presentation (invited, special)
-
Development of immunotherapy combined with in site tumor destruction.
Yutakawa Kawakami
World Cancer Congress 2010 (SingaporeEXPO) ,
2010.06,Oral presentation (invited, special)
-
STAT3-inactivated dendritic cella caccination could induce stronger anti-tumor immune responses
Hidetoshi Sumimoto, Tomoko Iwata-Kajihara, Hiroyuki Mizuguchi, Kiyoshi Takeda, Yutaka Kawakami.
13th 2010American Society of Gene Therapy (Marriott Wardman park hotel, Washington,DC, USA) ,
2010.05,Oral presentation (general)
-
CCL2 is critical for immunoresistance in association with cancer EMT
Chie Kudo-Saito, Yutaka Kawakami
101thAnnual Meeting of American Association for Cancer Research (Walter E. Washington Convention Center(Washington DC.)) ,
2010.04,Oral presentation (general)
-
「慶應義塾大学医学部 がんへの挑戦 -基礎・臨床研究の最前線-」がん細胞と免疫系の相互作用の解明：効果的な免疫療法の開発を目指して
河上裕
慶應義塾生命科学シンポジウム (慶応義塾大学医学部北里講堂) ,
2010.02,Oral presentation (general)